Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

Hong Kong · Delayed Price · Currency is HKD

227.20

+7.40 (3.37%)

Last updated: May 19, 2026, 11:57 AM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Pharmaceuticals	316.63M	212.47M
Pharmaceuticals Growth	49.03%	-
Total	316.63M	212.47M
Total Growth	49.03%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Mainland China	316.63M	212.47M
Mainland China Growth	49.03%	-
Total	316.63M	212.47M
Total Growth	49.03%	-

Source: S&P Global Market Intelligence.